These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25359366)

  • 1. The Clinical Trials Transformation Initiative: innovation through collaboration.
    Tenaerts P; Madre L; Archdeacon P; Califf RM
    Nat Rev Drug Discov; 2014 Nov; 13(11):797-8. PubMed ID: 25359366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient engagement in clinical trials: The Clinical Trials Transformation Initiative's leadership from theory to practical implementation.
    Patrick-Lake B
    Clin Trials; 2018 Feb; 15(1_suppl):19-22. PubMed ID: 29452519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clinical Trials Transformation Initiative: Methodology supporting the mission.
    Corneli A; Hallinan Z; Hamre G; Perry B; Goldsack JC; Calvert SB; Forrest A
    Clin Trials; 2018 Feb; 15(1_suppl):13-18. PubMed ID: 29452520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A decade of the Clinical Trials Transformation Initiative: What have we accomplished? What have we learned?
    Tenaerts P; Madre L; Landray M
    Clin Trials; 2018 Feb; 15(1_suppl):5-12. PubMed ID: 29452517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Clinical Trials Transformation Initiative (CTTI).
    Grignolo A
    Ann Ist Super Sanita; 2011; 47(1):14-8. PubMed ID: 21430332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Clinical Trials Transformation Initiative: Looking back, looking forward.
    Alexander JH; Corrigan-Curay J; McClellan M
    Clin Trials; 2018 Feb; 15(1_suppl):3-4. PubMed ID: 29452518
    [No Abstract]   [Full Text] [Related]  

  • 7. Improving Conduct and Feasibility of Clinical Trials to Evaluate Antibacterial Drugs to Treat Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia: Recommendations of the Clinical Trials Transformation Initiative Antibacterial Drug Development Project Team.
    Knirsch C; Alemayehu D; Botgros R; Comic-Savic S; Friedland D; Holland TL; Merchant K; Noel GJ; Pelfrene E; Reith C; Santiago J; Tiernan R; Tenearts P; Goldsack JC; Fowler VG
    Clin Infect Dis; 2016 Aug; 63 Suppl 2():S29-36. PubMed ID: 27481950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Rules of Engagement: CTTI Recommendations for Successful Collaborations Between Sponsors and Patient Groups Around Clinical Trials.
    Bloom D; Beetsch J; Harker M; Hesterlee S; Moreira P; Patrick-Lake B; Selig W; Sherman J; Smith SK; Valentine JE; Roberts JN
    Ther Innov Regul Sci; 2018 Mar; 52(2):206-213. PubMed ID: 29714514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evolution of clinical trials: Can we address the challenges of the future?
    Eichler HG; Sweeney F
    Clin Trials; 2018 Feb; 15(1_suppl):27-32. PubMed ID: 29452522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving Cardiovascular Drug and Device Development and Evidence Through Patient-Centered Research and Clinical Trials: A Call to Action From the Value in Healthcare Initiative's Partnering With Regulators Learning Collaborative.
    Warner JJ; Crook HL; Whelan KM; Bleser WK; Roiland RA; Hamilton Lopez M; Saunders RS; Wang TY; Hernandez AF; McClellan MB; Califf RM; Brown N;
    Circ Cardiovasc Qual Outcomes; 2020 Jul; 13(7):e006606. PubMed ID: 32683985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Legal, Regulatory, and Practical Issues to Consider When Adopting Decentralized Clinical Trials: Recommendations From the Clinical Trials Transformation Initiative.
    Apostolaros M; Babaian D; Corneli A; Forrest A; Hamre G; Hewett J; Podolsky L; Popat V; Randall P
    Ther Innov Regul Sci; 2020 Jul; 54(4):779-787. PubMed ID: 32557302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sponsors' and investigative staffs' perceptions of the current investigational new drug safety reporting process in oncology trials.
    Perez R; Archdeacon P; Roach N; Goodwin R; Jarow J; Stuccio N; Forrest A
    Clin Trials; 2017 Jun; 14(3):225-233. PubMed ID: 28345368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trial quality: From supervision to collaboration and beyond.
    Meeker-O'Connell A; Glessner C
    Clin Trials; 2018 Feb; 15(1_suppl):23-26. PubMed ID: 29452521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Streamlining Safety Data Collection in Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia Trials: Recommendations of the Clinical Trials Transformation Initiative Antibacterial Drug Development Project Team.
    Donnelly H; Alemayehu D; Botgros R; Comic-Savic S; Eisenstein B; Lorenz B; Merchant K; Pelfrene E; Reith C; Santiago J; Tiernan R; Wunderink R; Tenaerts P; Knirsch C
    Clin Infect Dis; 2016 Aug; 63 Suppl 2():S39-45. PubMed ID: 27481952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prototypical process for creating evidentiary standards for biomarkers and diagnostics.
    Altar CA; Amakye D; Bounos D; Bloom J; Clack G; Dean R; Devanarayan V; Fu D; Furlong S; Hinman L; Girman C; Lathia C; Lesko L; Madani S; Mayne J; Meyer J; Raunig D; Sager P; Williams SA; Wong P; Zerba K
    Clin Pharmacol Ther; 2008 Feb; 83(2):368-71. PubMed ID: 18091762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inter-company collaboration for AIDS Drug Development: perspective on combination studies.
    McLaren C; Elkins M; Salgo M; Myers M; Benoit S; Warburg M
    Antiviral Res; 1996 Jan; 29(1):119-22. PubMed ID: 8721562
    [No Abstract]   [Full Text] [Related]  

  • 18. Transforming the Activation of Clinical Trials.
    Watters JT; Pitzen JH; Sanders LJ; Bruce VNM; Cornell AR; Cseko GC; Grace JS; Kwon PS; Kukla AK; Lee MS; Monosmith MD; Myren JD; Kottschade RS; Shaft MN; Weis JJA; Welter JC; Bharucha AE
    Clin Pharmacol Ther; 2018 Jan; 103(1):43-46. PubMed ID: 29105757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How confidential trial negotiations and agreements between the Food and Drug Administration and sponsors marginalize local institutional review boards, and what to do about it.
    Mann H
    Am J Bioeth; 2006; 6(3):22-4; discussion W49-50. PubMed ID: 16754442
    [No Abstract]   [Full Text] [Related]  

  • 20. Improving and sustaining the site investigator community: Recommendations from the Clinical Trials Transformation Initiative.
    Fordyce CB; Malone K; Forrest A; Hinkley T; Corneli A; Topping J; Roe MT
    Contemp Clin Trials Commun; 2019 Dec; 16():100462. PubMed ID: 31701037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.